# The Characteristics of Treatment Resistant Schizophrenia From the Illness Onset

> **NCT06128408** · — · UNKNOWN · sponsor: **Peking University** · enrollment: 300 (estimated)

## Conditions studied

- Treatment-resistant Schizophrenia

## Interventions

- **DRUG:** risperidone, olanzapine, aripiprazole

## Key facts

- **NCT ID:** NCT06128408
- **Lead sponsor:** Peking University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-01
- **Primary completion:** 2024-10-12
- **Final completion:** 2024-10-13
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06128408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06128408, "The Characteristics of Treatment Resistant Schizophrenia From the Illness Onset". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06128408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*